181 related articles for article (PubMed ID: 28233298)
1. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
2. Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer.
Li JB; Ruan YY; Hu B; Dong SS; Bi TN; Lin A; Yan WH
Oncotarget; 2017 Jul; 8(30):48854-48862. PubMed ID: 28415627
[TBL] [Abstract][Full Text] [Related]
3. HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer.
Lázaro-Sánchez AD; Salces-Ortiz P; Velásquez LI; Orozco-Beltrán D; Díaz-Fernández N; Juárez-Marroquí A
Clin Transl Oncol; 2020 Jul; 22(7):1166-1171. PubMed ID: 31748960
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
5. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
[TBL] [Abstract][Full Text] [Related]
6. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
7. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
[TBL] [Abstract][Full Text] [Related]
8. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
9. Characterising the prognostic potential of HLA-DR during colorectal cancer development.
Dunne MR; Phelan JJ; Michielsen AJ; Maguire AA; Dunne C; Martin P; Noonan S; Tosetto M; Geraghty R; Fennelly D; Sheahan K; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2020 Aug; 69(8):1577-1588. PubMed ID: 32306077
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
Lin A; Zhang X; Zhou WJ; Ruan YY; Xu DP; Wang Q; Yan WH
Int J Cancer; 2011 Sep; 129(6):1382-90. PubMed ID: 21128238
[TBL] [Abstract][Full Text] [Related]
12. HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression.
Bossard C; Bézieau S; Matysiak-Budnik T; Volteau C; Laboisse CL; Jotereau F; Mosnier JF
Int J Cancer; 2012 Aug; 131(4):855-63. PubMed ID: 21953582
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of high circulating sHLA-G in ovarian carcinoma.
Babay W; Boujelbene N; Ben Yahia H; Bortolotti D; Zemni I; Ouzari HI; Chelbi H; Mezlini A; Rizzo R; Zidi I
HLA; 2021 Oct; 98(4):357-365. PubMed ID: 34272932
[TBL] [Abstract][Full Text] [Related]
14. Increased plasmatic soluble HLA-G levels in endometrial cancer.
Ben Yahia H; Babay W; Bortolotti D; Boujelbene N; Laaribi AB; Zidi N; Kehila M; Chelbi H; Boudabous A; Mrad K; Mezlini A; Di Luca D; Ouzari HI; Rizzo R; Zidi I
Mol Immunol; 2018 Jul; 99():82-86. PubMed ID: 29730546
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
[TBL] [Abstract][Full Text] [Related]
16. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
17. Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.
Adolf IC; Akan G; Mselle TF; Dharsee N; Namkinga LA; Atalar F
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3465-3472. PubMed ID: 31759373
[TBL] [Abstract][Full Text] [Related]
18. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases.
Zhu CB; Wang CX; Zhang X; Zhang J; Li W
Int J Cancer; 2011 Feb; 128(3):617-22. PubMed ID: 20473865
[TBL] [Abstract][Full Text] [Related]
19. Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
Ben Amor A; Beauchemin K; Faucher MC; Hamzaoui A; Hamzaoui K; Roger M
PLoS One; 2016; 11(8):e0161210. PubMed ID: 27517300
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer.
Mejía-Guarnizo LV; Monroy-Camacho PS; Rincón-Rodríguez DE; Rincón-Riveros A; Martinez-Vargas DA; Huertas-Caro CA; Oliveros-Wilches R; Sanchez-Pedraza R; Nuñez-Lemus M; Cristancho-Lievano CF; Castellanos-Moreno AM; Martinez-Correa LM; Rodríguez-García JA
Sci Rep; 2023 Aug; 13(1):13119. PubMed ID: 37573450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
